Yidu Tech's Affiliate Secures Contract for Shanghai Pulmonary Hospital Data Platform Upgrade

Stock News
Yesterday

YIDU TECH (02158) has announced that its affiliated company, Yidu Cloud (Beijing) Technology Co., Ltd., has received a notice of award for the Shanghai Pulmonary Hospital data platform domestic adaptation and upgrade project, with a total contract value of approximately RMB 3.57 million. The award result has been publicly announced on the National Public Resources Trading Platform (Shanghai).

This project underscores YIDU TECH's role as a key driver in advancing the intelligent upgrade of China's healthcare system. The company deeply empowers the entire industry chain spanning "medicine, pharmaceuticals, insurance, and patients" through smart decision-making, with a commitment to making precision medicine accessible to every individual.

By simulating doctors' clinical decision-making logic, training on real disease progression pathways, and repeatedly validating in real-world settings, YIDU TECH has developed an "AI that truly understands diseases." The company delivers measurable value to critical segments of the healthcare ecosystem: equipping doctors with more precise and efficient decision-making tools, shortening the distance from molecule to patient for pharmaceutical companies, enabling patients to access more affordable precision diagnostics and treatments, and providing public systems with stronger scientific support.

With system-level intelligence driven by independent innovation, YIDU TECH is committed to creating a more resilient, compassionate, inclusive, and efficient healthcare future.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10